Literature DB >> 26792853

Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.

A G Laurinavicius1, M S Bittencourt2, M J Blaha3, F C Nary4, N M Kashiwagi4, R D Conceiçao4, R S Meneghelo4, R R Prado4, J A M Carvalho4, K Nasir5, R S Blumenthal3, R D Santos6.   

Abstract

AIMS: Non-alcoholic hepatic steatosis (HS) is associated with hypertension and increased cardiovascular risk. While Blood pressure hyper-reactive response (HRR) during peak exercise indicates an increased risk of incident hypertension and increased cardiovascular risk, no data on the association of non-alcoholic HS and HRR exists. In this study, we have evaluated the association of HS with HRR.
METHODS: We included 13 410 consecutive individuals with a mean age: 42.4  ±  8.9 years, 3561 (26.6%) female with normal resting blood pressure and without a previous diagnosis of hypertension, who underwent symptom limited exercise treadmill test, abdominal ultrasonography and clinical and laboratory evaluation. HS was detected by abdominal ultrasonography. HRR was defined by a peak exercise systolic blood pressure  >220 mmHg and/or elevation of 15 mmHg or more in diastolic blood pressure from rest to peak exercise.
RESULTS: The prevalence of HS was 29.5% (n  =  3956). Overall, 4.6% (n  =  619) of the study population presented a HRR. Subjects with HS had a higher prevalence of HRR (8.1 vs. 3.1%, odds ratio 2.8, 95% CI 2.4-3.3, P  <  0.001). After adjustment for body mass index, waist circumference, fasting plasma glucose and low density lipoprotein cholesterol, HS (odds ratio 1.4, 95% CI 1.1-1.6, P  =  0.002) remained independently associated with HRR. HS was additive to obesity markers in predicting exercise HRR.
CONCLUSIONS: Non-alcoholic HS is independently associated with hyper-reactive exercise blood pressure response.
© The Author 2016. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 26792853      PMCID: PMC4986427          DOI: 10.1093/qjmed/hcw003

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  42 in total

1.  Prognostic significance of exercise blood pressure and heart rate in middle-aged men.

Authors:  J Filipovský; P Ducimetière; M E Safar
Journal:  Hypertension       Date:  1992-09       Impact factor: 10.190

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 3.  Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.

Authors:  Paola Loria; Amedeo Lonardo; Giovanni Targher
Journal:  Clin Sci (Lond)       Date:  2008-07       Impact factor: 6.124

Review 4.  Hypertension and fatty liver: guilty by association?

Authors:  M J Brookes; B T Cooper
Journal:  J Hum Hypertens       Date:  2007-02-01       Impact factor: 3.012

5.  Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.

Authors:  Saverio Stranges; Maurizio Trevisan; Joan M Dorn; Jacek Dmochowski; Richard P Donahue
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

6.  Clinical association between non-alcoholic fatty liver disease and the development of hypertension.

Authors:  Jae-Hong Ryoo; Young Ju Suh; Ho Cheol Shin; Yong Kyun Cho; Joong-Myung Choi; Sung Keun Park
Journal:  J Gastroenterol Hepatol       Date:  2014-11       Impact factor: 4.029

7.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.

Authors:  Ruben Hernaez; Mariana Lazo; Susanne Bonekamp; Ihab Kamel; Frederick L Brancati; Eliseo Guallar; Jeanne M Clark
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

8.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

Review 9.  The role of hepatokines in metabolism.

Authors:  Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2013-01-22       Impact factor: 43.330

10.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.